ALT vs HBAN · rev $5.0K vs P/E 13, rev $1.56B
Altimmune Inc (ALT) versus Huntington Bancshares Incorporated (HBAN) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Latest reported ALT revenue for 2025-09-30 was $5.0K. Net income was -$60.7M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ALT currently screens at market cap $527.0M.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
ALT currently screens at market cap $527.0M. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Not investment advice. Open the ALT and HBAN stock pages for the full models.
Not investment advice.